Cardinal Health (CAH) raises FY26 outlook

Cardinal Health (CAH) raises FY26 outlook; adj. EPS seen at least USD 10.00 (exp. 9.86, prev. 9.65-9.85)

• Cardinal Health (CAH) anticipates its Specialty revenues to exceed USD 50 billion by fiscal 2026, reflecting a 16% CAGR over three years.
• The company has raised its adjusted EPS forecast for FY26 to at least $10.00, surpassing previous expectations.
• Pre-market trading shows CAH shares up by 1.3%, indicating positive market sentiment.

Cardinal Health (CAH) has revised its fiscal 2026 outlook, projecting significant growth in its Specialty revenues and adjusted earnings per share (EPS). The company now expects its Specialty revenues to surpass USD 50 billion, representing a compounded annual growth rate (CAGR) of 16% over the next three years. This optimistic forecast was shared during the JP Morgan Healthcare Conference, highlighting Cardinal Health's strategic progress and growth potential.

In addition to revenue projections, Cardinal Health has also increased its adjusted EPS forecast for fiscal year 2026 to at least $10.00, up from the previously expected range of $9.65-$9.85. This adjustment surpasses the market's anticipated EPS of $9.86, reflecting the company's confidence in its financial performance and strategic initiatives.

The market has responded positively to these announcements, with Cardinal Health's stock (CAH) rising by 1.3% in pre-market trading. This uptick suggests that investors are optimistic about the company's growth trajectory and its ability to deliver on its revised financial targets.

Cardinal Health's focus on expanding its Specialty segment is seen as a strategic move to capitalise on the growing demand for specialised healthcare services. The company's ability to achieve a 16% CAGR in this segment could position it favourably within the healthcare sector, which is increasingly driven by innovation and specialised care solutions.

Market participants are closely monitoring Cardinal Health's performance, particularly in light of its revised financial outlook. The company's ability to meet or exceed these projections will be a key factor in sustaining investor confidence and driving future stock performance.

Trader Insight:
Some traders may consider monitoring CAH for further developments following its revised fiscal outlook. The healthcare sector, particularly companies with strong growth projections like Cardinal Health, could attract increased attention. Additionally, market participants might assess the impact of Cardinal Health's performance on healthcare ETFs such as XLV, which could reflect broader sector trends. Observers are also likely to watch the USD for any currency fluctuations that could affect international revenue streams for companies like Cardinal Health.

Disclaimer: This is not trading advice. For informational purposes only.